Crestwood Advisors Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Crestwood Advisors Group's EXAS Position: Q1 2026 in Review
Crestwood Advisors Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,046 shares — an estimated $614K sold.
Crestwood Advisors Group first reported a position in EXAS in Q3 2023 and held it in 9 quarters. The position peaked at $614K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Crestwood Advisors Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Crestwood Advisors Group sold 6,046 Exact Sciences shares in Q1 2026, an estimated $614K.
- Crestwood Advisors Group first reported a position in Exact Sciences in Q3 2023 and held it in 9 quarters.
- Crestwood Advisors Group's Exact Sciences position peaked at $614K in Q4 2025.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.